Literature DB >> 19158965

Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy.

E Nelaj1, M Gjata, I Lilaj, G Burazeri, E Sadiku, L Collaku, O Bare, M Tase.   

Abstract

BACKGROUND: Microalbuminuria was originally established as a predictor of renal failure and an independent risk factor for cardiovascular disease in patients with diabetes mellitus as well as in general population. The aim of our study is to assess the relationship between microalbuminuria and the other risk factors in diabetics and their prevalence.
METHODS: Sixty five patients, 22 men and 43 women with mean age 58.6+/-10.09, with type 2 diabetes, were hospitalized in the Department of Internal Medicine in the University Hospital Center "Mother Teresa" in Tirana, Albania, between March 2007 and February 2008. These patients with a mean duration of diabetes 6.09+/-5.41 were divided in two groups: with (Group A: 24 patients) and without (Group B: 41 patients) microalbuminuria and each group was evaluated for left ventricular mass index (LVMI), body mass index (BMI), glycosylated hemoglobin (HbA1C), lipid profile and intima media thickness (IMT).
RESULTS: The prevalence of microalbuminuria in our study was 32.3%. The prevalence of microalbuminuria in males was 37.5 and in females 62.5%. The microalbuminuric patients were older ( 59.71+/-9.87 vs 57.07+/-10.32) and had a longer duration of diabetes (7.74+/-5.74 vs 4.45+/-5.08) compared with normoalbuminuric patients (p=0.01). The Group A had significantly higher LVMI compared with Group B ( p=0.02). The prevalence of obesity (BMI>30 kg/m2) in our sample was 44.6%. In Group A the mean BMI (30.13+/-4.98) was significantly higher compared with Group B (28.00+/-3.72, p=0.04). Diabetic retinopathy was more frequent in Group A compared with Group B ( 33.3% vs 14.6%, p=0.05). The mean value of IMT was higher in Group A compared with Group B (1.28+/-0.35 vs 1.09+/-0.28, p=0.03).
CONCLUSION: In patients with type 2 diabetes and microalbuminuria LVMI, IMT, BMI, duration of diabetes was significantly higher compared with patients with type 2 diabetes and normoalbuminuria.

Entities:  

Keywords:  cardiovascular risk; microalbuminuria; nephropathy; type 2 diabetes

Year:  2008        PMID: 19158965      PMCID: PMC2580043     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  25 in total

1.  Screening for type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

Review 2.  Diabetic retinopathy.

Authors:  Robert N Frank
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

3.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

Review 4.  Diabetes mellitus and hypertension.

Authors:  M Epstein; J R Sowers
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

5.  Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

Authors:  Kay-Tee Khaw; Nicholas Wareham; Sheila Bingham; Robert Luben; Ailsa Welch; Nicholas Day
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

6.  The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

Authors:  Thomas Almdal; Henrik Scharling; Jan Skov Jensen; Henrik Vestergaard
Journal:  Arch Intern Med       Date:  2004-07-12

7.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

8.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

9.  Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.

Authors:  G Charpentier; N Genès; L Vaur; J Amar; P Clerson; J P Cambou; P Guéret
Journal:  Diabetes Metab       Date:  2003-04       Impact factor: 6.041

10.  Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study.

Authors:  R Hiller; R D Sperduto; M J Podgor; F L Ferris; P W Wilson
Journal:  Am J Epidemiol       Date:  1988-08       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.